Vimarsana
Biggest News Aggregation in the World

Page 31 - Jason Ehrlich News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jason Ehrlich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jason Ehrlich Today - Breaking & Trending Today

Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein Occlusion - Vimarsana News

Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein Occlusion

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Kodiak Sciences Completes Enrollment in GLOW Phase 3 Clinical Trial of Tarcocimab Tedromer (KSI-301) in Patients with Non-Proliferative Diabetic Retinopathy - Vimarsana News

Kodiak Sciences Completes Enrollment in GLOW Phase 3 Clinical Trial of Tarcocimab Tedromer (KSI-301) in Patients with Non-Proliferative Diabetic Retinopathy

/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...

Kodiak Sciences Completes Enrollment in GLOW Phase 3 Clinical Trial of Tarcocimab Tedromer (KSI-301) in Patients with Non-Proliferative Diabetic Retinopathy - Vimarsana News

Kodiak Sciences Completes Enrollment in GLOW Phase 3 Clinical Trial of Tarcocimab Tedromer (KSI-301) in Patients with Non-Proliferative Diabetic Retinopathy

/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...

Kodiak Sciences Inc. (NASDAQ:KOD) Insider Jason Ehrlich Sells 2,282 Shares of Stock - Vimarsana News

Kodiak Sciences Inc. (NASDAQ:KOD) Insider Jason Ehrlich Sells 2,282 Shares of Stock

Kodiak Sciences Inc. (NASDAQ:KOD – Get Rating) insider Jason Ehrlich sold 2,282 shares of the firm’s stock in a transaction on Friday, June 17th. The shares were sold at an average price of $7.02, for a total transaction of $16,019.64. Following the completion of the transaction, the insider now owns 56,920 shares in the company, […]

Kodiak Sciences (NASDAQ:KOD) Rating Reiterated by Chardan Capital - Vimarsana News

Kodiak Sciences (NASDAQ:KOD) Rating Reiterated by Chardan Capital

Kodiak Sciences (NASDAQ:KOD – Get Rating)‘s stock had its “buy” rating reiterated by equities research analysts at Chardan Capital in a note issued to investors on Monday, Zacks.com reports. Other equities research analysts have also recently issued research reports about the company. Barclays dropped their price objective on Kodiak Sciences from $81.00 to $50.00 and […]